Synairgen (SYNG)

London
198.80
-0.40(-0.20%)
  • Volume:
    1,655,980
  • Bid/Ask:
    180.00/220.00
  • Day's Range:
    196.60 - 204.20

SYNG Overview

Prev. Close
199.2
Day's Range
196.6-204.2
Revenue
-
Open
199
52 wk Range
95.4-223.8
EPS
-0.1
Volume
1,655,980
Market Cap
400.27M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,841,714
P/E Ratio
-
Beta
-7.53
1-Year Change
17.63%
Shares Outstanding
201,341,825
Next Earnings Date
09 May 2022
What is your sentiment on Synairgen?
or
Market is currently closed. Voting is open during market hours.

Synairgen Company Profile

Employees
18

Synairgen plc is a drug discovery and development company. The Company’s primary focus is developing SNG001 (inhaled interferon beta) for the treatment of coronavirus disease (COVID-19) as potentially the host-targeted, broad-spectrum antiviral treatment delivered directly into the lungs. The Company is also engaged in the drug discovery and development of therapies for respiratory diseases, particularly in the areas, including severe asthma chronic obstructive pulmonary disease (COPD). The Company is developing SNG001, a formulation for inhalation containing the broad-spectrum antiviral protein interferon beta for the treatment of severe viral lung infections. The Company offers a range of products, including Cablivi, Orthoclone OKT3, Remicade and ReoPro. The Company uses its human biology BioBank platform to discover and develop therapies for respiratory disease. Using the BioBank platform, it has developed a number of tissue models, which include In vitro and Ex vivo models.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellStrong SellBuyStrong Buy
Technical IndicatorsStrong SellSellStrong SellSellStrong Buy
SummaryStrong SellSellStrong SellNeutralStrong Buy
  • Synairgen now Incorporated in U.S. Delaware, check out the US job vacancies on the new Synairgen website!
    0
    • The long awaited news looks as though it will drop any day now, all positive going forward, check out the new website!
      0
      • https://www.synairgen.com/umbraco/Surface/Download/GetFile?cid=cf2bb601-373f-46d7-8368-f2f11d59c798
        0
        • Positive news annoucement this morning: https://www.synairgen.com/umbraco/Surface/Download/GetFile?cid=cf2bb601-373f-46d7-8368-f2f11d59c798
          0
          • 300 target now surely
            0
            • Is this just short term investors taking profits or are their fundamentals forcing this down?
              0
              • why didn't I buy more when it was lower 😑
                0
                • it is cheaper now.
                  0
                • Are you doing any more tours soon? I enjoyed ‘The Tour that didn’t tour’?
                  0
              • News we have been waiting on is pushing the price. Further advancement for the use of the medication will only but prove this is a worthy company for investing in.. https://www.synairgen.com/umbraco/Surface/Download/GetFile?cid=12b78acd-7cf8-4cac-91cd-a39faff6c86e
                0
                • Like Omega Diagnostics, Synairgen is a yo-yo stock. Nonetheless, these pharmaceutical companies will deliver not only COVID drugs but medications/inhalers for many lung related conditions. If you do have positions then HOLD, you will be rewarded
                  0
                  • Thursday will be the day for infromation as to how company plans to rollout next year with irish subsiduary looks very very promsiing
                    2
                    • Write up in the guardian. Forecasted revenue of £582m & global approval early next year. Q4 is going to be explosive.
                      1
                      • Cheers Nathan, this could be what we have been waiting for, anyone who has shares in this and “other” COVID/respiratory delevoping medication companies should deliberate before selling out, its definate “HOLD”
                        1
                    • Poly RNS and H2 is news time. Time running out, so fomo
                      1
                      • What has initiated the sudden jump, i cannot find any news updates to reflect a 10++% increase?
                        1
                        • We are on the cusp, next week should bring some welcomed news
                          2
                          • When will this rocket?
                            1
                            • 300
                              1
                              • Short sellers forcing the price down, as usual 😤😤
                                1
                                • When will this rise to the moon?
                                  0
                                  • why is this dropping so much after good news?
                                    0
                                    • Same thoughts Ahmed!
                                      0
                                  • Why sell? Company are and will continue to develop inhalers for Covid which no one has intimated it miraculously disappear. Other than the above , it is a company researching medications for all lung diseases which regretably costs lives
                                    1
                                    • I don't think that anyone is against this company making inhalers that help people. But the cause for the huge drop appears to be that by the time they get this inhaler is ready for distribution the pandemic will likely be over. Yes there will be other uses of course, and that's great. But reading the last press release the company said that they were even surprised at how few, I believe only 2 patients, in the placebo group were admitted to hospital and they pulled through. Which implies the study really didn't show much effectiveness, unless it was showing covid isn't that bad afterall. Had they used their heads and taken the inhaler where it's really needed in places like India at the moment and really put it through it paces and actually helped some people along the way then I might have left my money invested in synairgen. But the truth is they are aiming for profit, so you can't expect people to hold out...if they try to help those poor folk in India, then I'd be back in.
                                      1
                                  • And for those that consider giving the “thumbs down” need to wake up and smell the coffee, this company and others developing such medicines will save lives...or have you shorted the stock and its going against your position....Just to reiterate, we need these companies and their scientists so please back them
                                    3
                                    • No reason for this to falter, but again the inhaler needs to work for both COVID and other lung conditions. If thats proved, then i agree with Andrew & Ahmed....👍👍
                                      2
                                      • 500 soon
                                        1
                                        • anyone think this is worth buying now?
                                          2
                                          • When is this stock going to the moon?
                                            2
                                            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.